Global Diabetes Management Market Growth (Status and Outlook) 2023-2029

Global Diabetes Management Market Growth (Status and Outlook) 2023-2029

Diabetes, scientifically known as diabetes mellitus, is a clinical condition where person has an elevated blood glucose level.

LPI (LP Information)' newest research report, the “Diabetes Management Industry Forecast” looks at past sales and reviews total world Diabetes Management sales in 2022, providing a comprehensive analysis by region and market sector of projected Diabetes Management sales for 2023 through 2029. With Diabetes Management sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diabetes Management industry.

This Insight Report provides a comprehensive analysis of the global Diabetes Management landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diabetes Management portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diabetes Management market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diabetes Management and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diabetes Management.

The global Diabetes Management market size is projected to grow from US$ 5252.3 million in 2022 to US$ 13140 million in 2029; it is expected to grow at a CAGR of 14.0% from 2023 to 2029.

It occurs due to either inefficiency of pancreases to produce insulin (Type I) or unresponsiveness of body cells to the produced insulin (Type II) or both. This condition specifically results in polyuria, increase in thrust and hunger. This condition specifically results in polyuria, increase in thrust and hunger.

This report presents a comprehensive overview, market shares, and growth opportunities of Diabetes Management market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Monitoring Devices
Diagnostic Devices
Insulin Delivery Devices
Other Devices

Segmentation by application
Hospital
Clinic
Home Care

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Ascensia Diabetes Care
Abbott Laboratories
Medtronic
Roche
Dexcom
Insulet Corporation
Tandem Diabetes Care
LifeScan
AgaMatrix
Animas
ARKRAY
BD
Beta Bionics.
Eli Lilly

Please note: The report will take approximately 2 business days to prepare and deliver.